Altrova Health (FRA:WF8) Cash Conversion Cycle: -1,146.52 (As of Mar. 2026)


What is Altrova Health Cash Conversion Cycle?

Altrova Health FRA:WF8 Cash Conversion Cycle is -1,146.52 as of Mar. 2026. The stock has 3 warning signs investors should review.

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Altrova Health's Days Sales Outstanding for the three months ended in Mar. 2026 was 0.
Altrova Health's Days Inventory for the three months ended in Mar. 2026 was 44.15.
Altrova Health's Days Payable for the three months ended in Mar. 2026 was 1190.67.
Therefore, Altrova Health's Cash Conversion Cycle (CCC) for the three months ended in Mar. 2026 was -1,146.52.

Altrova Health  (FRA:WF8) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.

Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.

Altrova Health Cash Conversion Cycle Related Terms

Altrova Health Cash Conversion Cycle Historical Data

* Premium members only.

The historical data trend for Altrova Health's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Altrova Health Cash Conversion Cycle Chart

Altrova Health Annual Data
Trend Sep23 Sep24 Sep25
Cash Conversion Cycle
0.00 0.00 -1,643.20

Altrova Health Quarterly Data
Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -7,516.71 -846.01 0.00 -1,146.52

FRA:WF8 vs BLK, BX, KKR: Cash Conversion Cycle Comparison

For the Asset Management subindustry, Altrova Health's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Altrova Health Cash Conversion Cycle vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Altrova Health's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Altrova Health's Cash Conversion Cycle falls into.


Altrova Health Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Altrova Health's Cash Conversion Cycle for the fiscal year that ended in Sep. 2025 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=1176.11+0-2819.31
=-1,643.20

Altrova Health's Cash Conversion Cycle for the quarter that ended in Mar. 2026 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=0+44.15-1190.67
=-1,146.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Conversion Cycle →
What does a Cash Conversion Cycle of -1,146.52 mean?
Altrova Health (FRA:WF8) has a Cash Conversion Cycle of -1,146.52 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Altrova Health and its competitors.
Is Altrova Health's Cash Conversion Cycle too high?
Altrova Health's current Cash Conversion Cycle is -1,146.52.
How does Altrova Health's Cash Conversion Cycle compare to BLK and BX?
Altrova Health's Cash Conversion Cycle of -1,146.52 can be compared against companies in the Asset Management industry. The industry median Cash Conversion Cycle is 4.18. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for an Asset Management company?
The median Cash Conversion Cycle among Asset Management companies is 4.18, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Altrova Health and its competitors. For the Asset Management industry, the median Cash Conversion Cycle is 4.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Altrova Health's current Cash Conversion Cycle is -1,146.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Altrova Health stock overvalued right now?
Altrova Health (FRA:WF8) has a current Cash Conversion Cycle of -1,146.52. The current Cash Conversion Cycle is -1,146.52. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Altrova Health (FRA:WF8), the current Cash Conversion Cycle is -1,146.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Altrova Health Business Description

Other Exchanges SSPLF:USAROVA:Canada
Address 666 Burrard Street, 25th Floor, Vancouver, BC, CAN, V6C 2X8
Altrova Health Inc is a Canadian public company building a growing portfolio of health solutions across detection, protection, treatment, and wellness. The Company is focused on supporting multiple products, brands, and growth pathways under one stronger corporate identity, expanding beyond any single product story to create a more durable business. The Company continues to evaluate opportunities to expand its product offerings across the public health and safety sector.